Functional and anatomic outcomes of brolucizumab in adults with neovascular age-related macular degeneration – The OCTOPUS cohort study

No authors have a proprietary interest in the submitted work.

Dr Eric Souied reports consulting fees from AbbVie, Bayer, Novartis, Roche and Teva.

Dr Aude Couturier reports consultancy for Abbvie, Bayer, Novartis, Roche, Horus, Zeiss.

Dr François Devin: Alcon, Bayer, Novartis, Thea, Zeiss, Roche.

Dr. Creuzot-Garcher MD PhD reports personal fees from Novartis, during the conduct of the study; personal fees from Allergan Abbvie, personal fees from Bayer, grants, personal fees and non-financial

Comments (0)

No login
gif